Company Description
MediPharm Labs Corp. is medicinal cannabis company, which engages in the pharmaceutical grade production of cannabis oil products. The company focuses on the downstream secondary extraction methodology, distillation, and cannabinoid isolation and purification. It supplies raw materials, formulations...
MediPharm Labs Corp. is medicinal cannabis company, which engages in the pharmaceutical grade production of cannabis oil products. The company focuses on the downstream secondary extraction methodology, distillation, and cannabinoid isolation and purification. It supplies raw materials, formulations, processing, and packaging for the creation of ready-to-sell derivative products. The company was founded by Patrick McCutcheon in 2015 and is headquartered in Barrie, Canada.
Valuation
P/E Current
39.69
P/E Ratio (without extraordinary items)
281.75
Price to Sales Ratio
4.02
Price to Book Ratio
3.86
Enterprise Value to EBITDA
47.29
Enterprise Value to Sales
3.80
Total Debt to Enterprise Value
0.02
Efficiency
Revenue/Employee
561,965.00
Income Per Employee
7,152.00
Receivables Turnover
7.61
Total Asset Turnover
1.22
Liquidity
Current Ratio
4.15
Quick Ratio
2.36
Cash Ratio
1.34
Profitability
Gross Margin
32.27
Operating Margin
6.08
Pretax Margin
5.22
Net Margin
1.27
Return on Assets
1.56
Return on Equity
2.07
Return on Total Capital
8.95
Return on Invested Capital
1.96
Capital Structure
Total Debt to Total Equity
8.04
Total Debt to Total Capital
7.44
Total Debt to Total Assets
6.27
Long-Term Debt to Equity
6.66
Long-Term Debt to Total Capital
6.16
Officers and Executives
Name | Age | Officer Since | Title |
---|---|---|---|
Mr. Patrick McCutcheon | - | 2015 | Chairman, President & Chief Executive Officer |
Mr. Keith Strachan | - | 2018 | Director & VP-Business Development |
Mr. Greg Hunter | - | 2021 | Chief Financial Officer |
Mr. Paul Hamelin | - | - | Vice President-Security & Information Technology |
Dr. Tait R. Gale | - | 2019 | Manager-Research & Development |
Insider Actions
MarketWatch News on MEDIF
-
MediPharm Labs started at buy at Alliance Global Partners
- Tomi Kilgore
-
Medipharm Labs names Robert Kwon new CFO
- Tomi Kilgore
-
Your investing guide to cannabis 2.0
- Michael Brush
-
Cronos to supply bulk cannabis to MediPharm Labs' extraction facility to fulfill processing needs
- Tomi Kilgore
-
MediPharm Labs to supply Cronos with C$30 mln of private-label cannabis concentrate
- Tomi Kilgore
-
Cronos enters multi-year supply agreement with MediPharm Labs
- Tomi Kilgore
Other News on MEDIF
-
MediPharm ups size of capital raise to $29M
- Seeking Alpha
-
MediPharm Labs enters $20M bought deal equity financing
- Seeking Alpha
-
Auxly: 2020 Was A Milestone, But It Came At Great Costs
- Seeking Alpha
-
- Seeking Alpha
-
MediPharm Labs: Undiscovered Gem In The Cannabis Sector
- Seeking Alpha
-
MediPharm Labs wins Cannabis Drug Licence from Health Canada
- Seeking Alpha
-
The New Dawn In Cannabis Has Arrived
- Seeking Alpha
-
Cannabis In California Will Boom Into A Powerhouse Opportunity
- Seeking Alpha
-
Cannabis Goes Green With Blue Victory, U.S. Stocks Will Soar
- Seeking Alpha
-
Cannabis Stocks: Outlook For 2021 And What To Look For
- Seeking Alpha
-
The Fastest Growing Cannabis Stocks And The Ones To Watch
- Seeking Alpha
-
The 20 Most Undervalued Cannabis Stocks
- Seeking Alpha
-
Cannabis Stocks Are Hot Again And Here Are Some You Should Buy
- Seeking Alpha
-
The 5 Best Marijuana ETFs for Conservative Portfolios
- InvestorPlace.com
- Loading more headlines...